Repurposing Approved Drugs for Guiding COVID-19 Prophylaxis: A Systematic Review
The SARS-CoV-2 outbreak originally appeared in China in December 2019 and became a global pandemic in March 2020. This infectious disease has directly affected public health and the world economy. Several palliative therapeutic treatments and prophylaxis strategies have been used to control the prog...
Saved in:
Main Authors: | Bruno Silva Andrade (Author), Fernanda de Souza Rangel (Author), Naiane Oliveira Santos (Author), Andria dos Santos Freitas (Author), Wagner Rodrigues de Assis Soares (Author), Sérgio Siqueira (Author), Debmalya Barh (Author), Aristóteles Góes-Neto (Author), Alexander Birbrair (Author), Vasco Ariston de Carvalho Azevedo (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2020-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pan-Resistome Insights into the Multidrug Resistance of <i>Acinetobacter baumannii</i>
by: Diego Lucas Neres Rodrigues, et al.
Published: (2021) -
Computational and Experimental Drug Repurposing of FDA-Approved Compounds Targeting the Cannabinoid Receptor CB1
by: Emanuele Criscuolo, et al.
Published: (2023) -
Repurposing Approved Drugs for Sarcopenia Based on Transcriptomics Data in Humans
by: Shuang Liang, et al.
Published: (2023) -
In silico approaches for drug repurposing in oncology: a scoping review
by: Bruno Raphael Ribeiro Cavalcante, et al.
Published: (2024) -
Repurposing FDA-approved sulphonamide carbonic anhydrase inhibitors for treatment of Neisseria gonorrhoeae
by: Nader S. Abutaleb, et al.
Published: (2022)